Randomized Controlled Trial on Pancreatic Stent Tube in Pancreaticoduodenectomy

Sponsor
Wakayama Medical University (Other)
Overall Status
Completed
CT.gov ID
NCT00628186
Collaborator
(none)
100
1
1
34
2.9

Study Details

Study Description

Brief Summary

The purpose of this study is to determine which stent type is effective in the decrease of postoperative stay and complications across pancreaticojejunostomy after pancreaticoduodenectomy.

Condition or Disease Intervention/Treatment Phase
  • Device: external drainage tube [polyethylene pancreatic drainage tube]
  • Device: internal drainage tube [polyethylene pancreatic drainage tube]
N/A

Detailed Description

This study compared the postoperative hospital stay and complications of lost stent with external stent after pancreaticoduodenectomy. The complications of pancreaticoduodenectomy are important to affect the postoperative course, and, a stent tube often places across pancreaticojejunostomy to reduce complications. However, there is no report that demonstrates the postoperative course between pancreatic stent types. We conducted a prospective randomized trial on 100 patients who underwent pancreaticoduodenectomy comparing external stent and lost stent.

The primary endpoint was defined as postoperative hospital stay. The secondary endpoints were mortality and morbidity, including pancreatic fistula, delayed gastric emptying, intra-abdominal hemorrhage, and intra-abdominal abscess. Patients were recruited into this study before surgery, on the basis of whether pancreatic head resection was anticipated at WMUH for pancreatic head and periampullary disease, and appropriate informed consent was obtained. Exclusion criteria was 1) patients with severe complications which were possible to prolong hospital stay, 2) patients who were diagnosed inadequacy for this study by a physician, 3) patients who could not be placed a pancreatic stent tube, and 4) patients without an informed consent.

Study Design

Study Type:
Interventional
Actual Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Prospective, Randomized, and Controlled Trial That Lost Stent Versus External Stent of Pancreaticojejunostomy After Pancreaticoduodenectomy
Study Start Date :
Apr 1, 2005
Actual Primary Completion Date :
Aug 1, 2007
Actual Study Completion Date :
Feb 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

Pancreaticojejunostomy has a risk factor of pancreatic fistula. Type of stent tube (external stent vs. short stent)across pancreaticojejunostomy was randomized for the patients with pancreaticoduodenectomy.

Device: external drainage tube [polyethylene pancreatic drainage tube]
External drainage tube was intubated with a 5F polyethylene pancreatic drainage tube with a small knob (Sumitomo Bakelite Co., Japan)(MD41515) across pancreaticojejunostomy in pancreaticoduodenectomy, and exteriorized through the jejunal limb.
Other Names:
  • polyethylene pancreatic drainage tube(S/N MD41515)
  • Device: internal drainage tube [polyethylene pancreatic drainage tube]
    Internal drainage tube was intubated 5cm length of stent tube cut a 5F polyethylene pancreatic drainage tube with a small knob across pancreaticojejunostomy in pancreaticoduodenectomy, and pancreatic juice was led to reconstructed jejunum.
    Other Names:
  • polyethylene pancreatic drainage tube(S/N MD41515)
  • Outcome Measures

    Primary Outcome Measures

    1. the length of hospital stay after pancreaticoduodenectomy [the day of discharge]

    Secondary Outcome Measures

    1. early and late complications after pancreaticoduodenectomy [6 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • On the basis of whether pancreatic head resection was anticipated at WMUH for pancreatic head and periampullary disease, and appropriate informed consent was obtained.
    Exclusion Criteria:
    • Patients with severe complications which were possible to prolong hospital stay

    • Patients who were diagnosed inadequacy for this study by a physician

    • Patients who could not be placed a pancreatic stent tube

    • Patients without an informed consent.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Wakayama Medical University , Second Department of Surgery 811-1 Kimiidera, Wakayama Wakayama Japan 641-8510

    Sponsors and Collaborators

    • Wakayama Medical University

    Investigators

    • Study Director: Masaji Tani, MD, Wakayama Medical University, Second Department of Surgery

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00628186
    Other Study ID Numbers:
    • WP-0501
    First Posted:
    Mar 4, 2008
    Last Update Posted:
    Jan 18, 2010
    Last Verified:
    Jan 1, 2010

    Study Results

    No Results Posted as of Jan 18, 2010